A Study on Sildenafil Citrate in the treatment of IUGR & Oligohydramnios'
Teks penuh
Dokumen terkait
In 1998, the Food and Drug Administration (FDA) approved Nolvadex-Tamoxifen Citrate for diminishing the occurrence of breast cancer in women who is at high risk of developing
A set of data point or observation, which also known as subgroup, from time to time is sampled from the process, and parameter such as the ambulance response time, rate of medical
A Systematic Review by Levine et al., have reported that 6-36 months old children with a history of IUGR were at higher risk for impaired different domains of neurodevelopmental
Current available strategies for nanoparticle mediated cancer treatment includes nanomedicines, immune checkpoint blockade therapy, biomimetic nanoparticles, different types of
Table 2- Examined PARP inhibitor in the treatment of Prostate Cancer Grewal et al., 2021 Clinical trial name Primary objective Takeaways Rucaparib FDA approved Triton2
Effects of Immediate and Delayed Loading on the Outcomes of All-on-4 Treatment: A Prospective Study Hossein Najafi 1, Hakimeh Siadat 2, Solmaz Akbari 3, Amirreza Rokn 4 1
iii TABLE OF CONTENT Acknowledgements Abstract Table of Content iv-v CHAPTER 1 INTRODUCTION Introduction 1-2 Statementof the problem 2-3 Purposeof the Study 4 Significanceof the
Ini menyatakan bahwa kombinasi pengobatan sildenafil 2mg/kg 3x1 dengan bosentan 1mg/kg 2x1 lebih efektif untuk meningkatkan kejadian pengurangan waktu rawat inap pada pasien bayi dengan
